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Purpose: Radiation Pneumonitis (RP) limits radiotherapy. Detection of early metabolic changes in the
lungs associated with RP may provide an opportunity to adjust treatment before substantial toxicities
occur. In this work, regional lactate-to-pyruvate signal ratio (lac/pyr) was quantiﬁed in rat lungs and
heart following administration of hyperpolarized 13C-pyruvate magnetic resonance imaging (MRI) at
day 5, 10, 15 and 25-post conformal radiotherapy. These results were also compared to histology and
blood analyses.
Methods: The lower right lungs of 12 Sprague Dawley rats were irradiated in 2 fractions with a total dose
of 18.5 Gy using a modiﬁed micro-CT system. Regional lactate and pyruvate data were acquired from
three irradiated and three age-matched healthy rats at each time point on days 5, 10, 15 and 25-post
radiotherapy. Arterial blood was collected from each animal prior to the 13C-pyruvate injection and
was analyzed for blood lactate concentration and arterial oxygen concentration (paO2). Macrophage
count was computed from the histology of all rat lungs.
Results: A signiﬁcant increase in lac/pyr was observed in both right and left lungs of the irradiated cohort
compared to the healthy cohort for all time points. No increase in lac/pyr was observed in the hearts of
the irradiated cohort compared to the hearts of the healthy cohorts. Blood lactate concentration and paO2
did not show a signiﬁcant change between the irradiated and the healthy cohorts. Macrophage count in
both right and left lungs was elevated for the irradiated cohort compared to the healthy cohort.
Conclusions: Metabolic changes associated with RP may be mapped as early as ﬁve days post conformal
radiotherapy. Over the small sample size in each cohort, elevated macrophage count, consistent with
early phase of inﬂammation was highly correlated to increases in lac/pyr in both the irradiated and unir-
radiated lungs. Further experiments with larger sample size may improve the conﬁdence of this ﬁnding.
 2014 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 110 (2014) 317–322
Open access under CC BY-NC-SA license.Lung cancer continues to be responsible for the highest number
of cancer related deaths [1,2]. Radiotherapy is a primary treatment
method for lung cancer [3] but limited by adverse consequences
due to the high radio-sensitivity of the lung [4]. A major side effect
of thoracic radiotherapy is Radiation Pneumonitis (RP) and can
proceed to irreversible lung ﬁbrosis in the later stages [3]. RP oc-
curs in up to 37% of lung cancer patients receiving radiotherapy[3,5], with moderate to severe RP occurring in about 20% of
patients [6].
Early detection of RP using imaging could potentially improve
patient outcome by appropriate modiﬁcation of the radiotherapy
treatment plan, dose-reduction in chemotherapy and/or adminis-
tration of corticosteroids to help reduce inﬂammation [7]. Chest
X-ray and Computed Tomography (CT) imaging are the most com-
monly usedmethods for detection of Radiation-Induced Lung Injury
(RILI) in the clinic. These techniques detect changes in lung density
and can be useful for the evaluation of ﬁbrosis associated with late
stage injuries [8]. Three-dimensional (3D) CT has been used to pro-
vide lung dose–volume histogram (DVH) parameters to forecast
318 Early detection of Radiation Induced Lung Injurythedevelopmentof RP [9]; however, theseparametershavevery low
predictive powers [3]. Nonetheless, someof theDVHparameters are
strongly correlated with the incidence of RP [10]. Recently, Positron
Emission Tomography has shown increased uptake of 18F-Fluorode-
oxyglucose associated with RP in lung cancer patients [7].
Despite the low proton signal afforded in the lung, Magnetic
Resonance Imaging (MRI) has been used for the detection of RP,
including Dynamic contrast-enhanced MRI [11] and T1- and T2-
weighted contrast MRI [12]. Recently, hyperpolarized 3He-MRI
has been used to detect RP post irradiation in lung cancer patients
[13]. However, all these techniques are based on morphological
and functional changes, which may occur in the later stages of in-
jury. Imaging biomarkers sensitive to early metabolic changes
associated with RP at the cellular level could provide an approach
for earlier detection of RILI.
At a cellular level, immunohistochemical analysis of RP in
animal models reveals underlying changes in DNA and increases
in alveolar macrophages, inﬂammatory cytokines and type II
pneumocytes [14,15]. These changes are observed in both
in-ﬁeld and out-of-ﬁeld post conformal radiotherapy [16,17],
and persist up to 4 weeks post irradiation. [18] Activation of
T-lymphocytes has also been observed as a protection mecha-
nism against radiation ﬁbrosis [19]. The occurrence of RP is
closely tied to the onset of inﬂammation, which is highly depen-
dent on the onset of inﬂammatory cytokines. [20] Additionally,
hypoxia in lung tissue plays a role in the mediation of inﬂam-
matory process in RP [21]. Decreased arterial partial pressure
of oxygen (paO2), which is used as an indicator of hypoxia
[13] has been reported following radiotherapy [22,23]. Recent
observations from lung cancer patients post irradiation suggest
a strong correlation between dynamic changes in CD35 and
onset of RP [24]; and between the amount of exhaled NO and
occurrence of RP [25].
Advances in Dynamic Nuclear Polarization (DNP) technique
have enabled the in vivo MRI of carbon-13 (13C) substrates [26].
The pyruvate molecule enriched with 13C at the C-1 position has
been used extensively as it can be polarized to a high degree and
the conversion of 13C-pyruvate to its metabolic products, 13C-lac-
tate, 13C-bicarbonate and 13C-alanine, has been readily observed
in vivo [27,28]. Speciﬁcally, changes in 13C-lactate to 13C-pyruvate
signal ratio (lac/pyr) have been used to measure lung ischemia
ex vivo [20]. Our research has previously demonstrated changes
in lac/pyr in a rat model of RILI at two weeks post whole thorax
irradiation [29].
The purpose of this work was to quantify regional lac/pyr
using hyperpolarized 13C Magnetic Resonance Spectroscopic
Imaging (MRSI) in a rat model of RP involving conformal radio-
therapy of the lung, 5, 10, 15 and 25 days post-irradiation. These
results were compared to those obtained in healthy age-matched
rats and correlated with quantitative (i.e. cell counting) histolog-
ical analysis of the lung following imaging. The potential origin of
lac/pyr changes in RP is discussed in terms of increases in
macrophage population.Methods
Animal irradiation
All procedures followed animal care protocols approved by
the Western University (ACVS) and were consistent with
procedures used by the Canadian Council on Animal Care
(CCAC). The right medial lobe of the lungs of 12 Sprague Dawley
rats (200 ± 50 g) was irradiated with a total dose of 18.5 Gy
(2  9.25 Gy, 24 h apart, respiratory-gated delivery) using a
modiﬁed micro-CT system (GE eXplore CT 120, GEHC, Wauke-
sha, WI) system [30]. Fig. 1 shows a representative conformaldose distribution in the lungs and heart region of rat thorax
for a single fraction (details provided in supplementary mate-
rial). A total of 12 irradiated and 12 age-matched healthy rats
were divided equally into four groups. One group was imaged
and sacriﬁced per time point (5, 10, 15 and 25 days post-irradi-
ation) for MRI and histology data.Blood lactate, paO2 measurements and histology preparation
To quantify the systemic spread of disease, blood lactate and
paO2 readings were acquired from each animal pre-MRI. Lung his-
tology was obtained from each animal post-MRI to quantify the
macrophage count (details provided in supplementary material).Magnetic resonance spectroscopy and imaging
Hyperpolarized 13C-pyruvate was prepared and administered as
previously described [29]. MRI and MRSI were also performed as
previously described [29] using a 3T MR imaging system (MR750,
GEHC, Waukesha, WI). For each cohort, rats were randomly chosen
and the measurements were performed in a blinded fashion. To re-
ceive 13C-MRSI signal, a custom 13C-surface coil was wrapped
around the animal thorax. The tray was then inserted into a cus-
tom-built, rat-sized quadrature dual-tuned (13H–13C) birdcage coil,
which was used to transmit/receive signal for 13H-MRI and to
transmit-only for 13C-MRSI.
1H MRI
T1-weighted 1H images of the rat thorax were acquired in the
coronal and axial planes with parameters described previously
[29]. These images were used to localize the 13C-MRSI volume of
interest within the lungs, as the lung boundary was well visualized
as a signal void compared to the other tissues (e.g. heart and liver).
13C-MRSI
MRSI was performed using a Chemical Shift Imaging (CSI)
technique as described previously [29]. A slab was placed above
the diaphragm with a margin sufﬁcient to minimize respiratory
motion related contamination of the heart and the lung signal
with liver signal. The slab was centered on the lungs and divided
into a 12  12 matrix with minimal coverage of the liver and the
heart. Spectroscopic imaging was initiated following a delay of
25 s from the start of the bolus injection to maximize the lactate
signal [29].
13C MRSI data processing and analysis
SAGE™ software (GEHC, Waukesha, WI) was used for process-
ing of the acquired data. The 13C-MRSI data were apodized with
a 10 Hz Gaussian ﬁlter in the time domain, zero-ﬁlled 1 in the
time dimension and both spatial dimensions. Fourier transforma-
tions were then performed in both the time domain and the two
spatial dimensions to obtain a 16  16 grid of spectra with each
voxel of dimensions: 3.75 mm  3.75 mm  8 mm. The metabolite
peaks were phased and baseline corrected for every voxel. The
16  16 grid of spectra was overlaid on the axial 1H image and
twelve voxels were chosen: four centered on the left lung, four
on the right lung and four on the heart. The relative positions of
these four voxels for each organ were kept consistent for each ani-
mal. The measure of lac/pyr for each group of four voxels was com-
puted by dividing the total lactate signal intensity by the total
pyruvate signal intensity. Two-tailed paired T-tests were per-
formed (with the assumption of unequal variance) for the blood
lactate concentration level, paO2 level, lac/pyr measurements from
the left lung, the right lung and the heart between the irradiated
cohort and the healthy cohort for each time point. A p-value of less
than 0.05 was considered signiﬁcant. A mixed analysis of variance
Fig. 1. Calculated dose distributions shown in (a) axial plane, (b) coronal plane and (c) sagittal planes. The yellow contour around the right lung represents the isodose line
corresponding to 9.25 Gy. Most of the heart region and left lung received minimal radiation (<0.5 Gy). The dose delivery was gated to the breathing cycle for accurate dose
deposition. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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using the SPSS software. (IBM, Markham, Ontario).
Results
Fig. 2 shows a typical CSI grid overlaid on the corresponding 1H
image for a representative irradiated rat, including the voxels
chosen for analysis of lac/pyr in the left lung, right lung and heart
region respectively. Fig. 3 provides a summary of the average
lac/pyr measurements obtained from these regions in both the
irradiated and healthy cohorts at day 5, 10, 15 and 25-post irradi-
ation. Both right and left lungs from the irradiated cohort show aFig. 2. 13C MRSI overlaid on T1-weighted 1H axial image. The lung boundary is
clearly visualized as a signal void. 13C measurements were made in twelve voxels,
four each from the left lung, right lung and the heart region indicated as (a), (b) and
(c), respectively. Voxel positions with respect to the 1H image were kept consistent
for all animals.signiﬁcant increase in lac/pyr compared to the right and left lung
from the healthy cohort respectively at each time point
(p < 0.05). This conﬁrms the response to radiation both at the site
of the irradiation (medial right lung) as well as the unirradiated
(i.e. contralateral) left lung.
Mixed analysis of variance demonstrated a signiﬁcant decrease
in lac/pyr at day 25 compared to day 10 in the right lung of the
irradiated cohort (p < 0.05), suggesting the RP has begun to sub-
side. Table 1 summarizes lac/pyr (mean ± ﬁrst standard deviation)
from the right lung, left lung and heart for the irradiated and
healthy cohorts for all time points.
Measured lac/pyr was not signiﬁcantly different in the heart re-
gion of the irradiated cohort compared to the heart region of the
healthy cohort at any time point post irradiation (p > 0.05). At
day 25, lac/pyr was lower in the heart region of the irradiated co-
hort compared to the heart region of the healthy cohort
(0.21 ± 0.01 vs. 0.25 ± 0.01, n = 3, p < 0.05). Analysis of the histology
from the heart region at day 10 and day 15-post irradiation con-
ﬁrmed the absence of injury.
Investigation of blood lactate concentration levels did not show
signiﬁcant changes between the irradiated and healthy cohorts at
any time point (p > 0.05) post irradiation with non-time point spe-
ciﬁc measurements being 1.22 ± 0.3 vs. 1.23 ± 0.31, n = 12, respec-
tively. Additionally, blood paO2 level measurements did not show
signiﬁcant changes between the irradiated and healthy cohorts at
any time point (p > 0.05) and paO2 did not drop below normal
(60 mmHg) for any of the irradiated cohorts. Measurement from
all irradiated and healthy cohorts (non-time point speciﬁc) were
80 ± 15 vs. 78 ± 14, n = 12, respectively. The conformal irradiation
of the right lung does not appear to compromise the paO2 and
might be explained by a compensatory effect of the unirradiated
lung, enabling adequate oxygen supply to the body. The heart tis-
sue is also substantially spared injury due to the conformal nature
of the irradiation, therefore not compromising cardiac function. In
addition to the conformal radiotherapy, the lower dose rate of the
radiation beam used in this study may have reduced the level of
tissue injury compared to our previous study [29].
The ﬁgure in the supplementary material shows a representa-
tive H&E stained section of the right lung at day 25 for both a
healthy and an irradiated rat with the macrophages marked by
Fig. 3. Measure of lac/pyr plotted for the right lung, left lung and heart regions in the healthy and irradiated cohorts at all four time points post irradiation. Statistically
signiﬁcant increases in lac/pyr (⁄⁄p < 0.01, ⁄p < 0.05) are apparent in the right and left lung of the irradiated cohort compared to right and left lung of either the healthy cohort
or the heart region of all rats at all time points post irradiation (mean ± 1 SD).
Table 1
Summary of lac/pyr from the right lung, left lung and heart regions and macrophage count from right and left lung of the irradiated and healthy cohorts at each time point post
conformal radiotherapy. Data are represented as mean ± ﬁrst standard deviation.
lac/pyr Macrophage count
Day 5 Day 10 Day 15 Day 25 Day 5 Day 10 Day 15 Day 25
Irradiated cohort right
lungs
0.37 ± 0.04
(n = 3)
0.39 ± 0.02
(n = 3)
0.37 ± 0.02
(n = 3)
0.33 ± 0.02
(n = 3)
18.13 ± 1.53
(n = 3)
14.80 ± 1.70
(n = 2)
14 ± 1.41
(n = 2)
13.80 ± 2.26
(n = 2)
Healthy cohort right
lungs
0.17 ± 0.06
(n = 3)
0.26 ± 0.06
(n = 3)
0.24 ± 0.03
(n = 3)
0.21 ± 0.03
(n = 3)
7.40 ± 1.56
(n = 3)
9.33 ± 3.39
(n = 3)
7.53 ± 1.15
(n = 3)
6.80 ± 0.35
(n = 3)
Irradiated cohort left
lungs
0.39 ± 0.04
(n = 3)
0.38 ± 0.07
(n = 3)
0.41 ± 0.08
(n = 3)
0.35 ± 0.03
(n = 3)
15.47 ± 1.81
(n = 3)
14.60 ± 1.13
(n = 2)
14.13 ± 1.50
(n = 3)
13.33 ± 1.70
(n = 3)
Healthy cohort left
lungs
0.17 ± 0.05
(n = 3)
0.22 ± 0.04
(n = 3)
0.21 ± 0.07
(n = 3)
0.20 ± 0.01
(n = 3)
7.13 ± 1.50
(n = 3)
9.30 ± 3.25
(n = 2)
8.07 ± 1.45
(n = 3)
6.47 ± 0.76
(n = 3)
Irradiated cohort heart 0.22 ± 0.04
(n = 3)
0.21 ± 0.03
(n = 3)
0.25 ± 0.04
(n = 3)
0.21 ± 0.01
(n = 3)
Healthy cohort heart 0.18 ± 0.01
(n = 3)
0.24 ± 0.05
(n = 3)
0.28 ± 0.08
(n = 3)
0.25 ± 0.01
(n = 3)
The quality of the histology was not acceptable to support manual counting of macrophages in some animals and as a result those animals were dropped from the
macrophage count. This resulted in some cohorts with a count of 2.
320 Early detection of Radiation Induced Lung Injuryblack arrows. Table 1 summarizes the macrophage count for the
right and left lung from irradiated and healthy cohorts for each
time point. Fig. 4 shows the time courses for average lac/pyr and
macrophage count and a scatter plot of the lac/pyr measurements
versus macrophage count for the right and left lung of all the rats
for all time points. Macrophage counts were observed to increase
in both the right and left lungs of the irradiated cohort compared
to the healthy cohort, following a trend similar to lac/pyr at each
time point. Non-parametric analysis of these data provided Spear-
man coefﬁcients (r) of 0.86 (p < 0.01) and 0.85 (p < 0.01) respec-
tively for the right and left lung.
Discussion
In this rat model of RP involving conformal irradiation of the
right lung, measures of lac/pyr were shown to be elevated in both
lungs at all time points following irradiation. This is consistent
with previous observations in a similar rat model, which showedthat cytokines and DNA damage persist 5–15 days and 3 days to
4 weeks post irradiation, respectively [18]. Signiﬁcant decreases
in lac/pyr in the right irradiated lung observed at day 25 compared
to day 10 may be evidence of reduced inﬂammation from the
receding initial phase of RP. This seems to be supported by the
reduction in measured macrophage activity at the later time points
(Fig. 4).
Additionally, lac/pyr increases conﬁrm the response of the
whole lungs to conformal radiotherapy, both at the site of irradia-
tion (medial right lung) and at the unirradiated contralateral side
(left lung). This observation is in agreement with previous ﬁndings,
which have demonstrated that conformal radiotherapy of the lungs
results in injury response of the lungs both in and out of the radi-
ation ﬁeld [16,17].
Measurements of lac/pyr did not show altered heart metabo-
lism at any time point. This was conﬁrmed by the analysis of the
histology from the heart region. Lack of increase in lac/pyr in the
heart region, increase in blood lactate levels and decrease in paO2
Fig. 4. Time evolution of lac/pyr in the healthy and irradiated cohorts in the right lung shown in (a) and in the healthy and irradiated cohorts in the left lung shown in (b).
Sub-plots (c) and (d) show progression of macrophage count in the healthy and irradiated cohorts in the right and left lung, respectively. Sub-plots (e) and (f) show scatter of
lac/pyr and macrophage count and the Spearman correlation coefﬁcient in the right lung (r = 0.86, p < 0.01) and the left lung (r = 0.85, p < 0.01), respectively (mean ± 1 SD).
K. Thind et al. / Radiotherapy and Oncology 110 (2014) 317–322 321in irradiated cohorts compared to healthy cohorts demonstrates
that the injury response was limited to the lungs with no systemic
effects. This conﬁrms that the irradiation conformed to the lungs,
sparing other surrounding tissues.Macrophage count in both the right and left lungs of the irradi-
ated cohorts was higher than the corresponding right and left lung
of healthy cohorts, which is in agreement with previous observa-
tions showing that macrophages are recruited from outside the
322 Early detection of Radiation Induced Lung Injurylung [31] and that these inﬁltrating macrophages are a source of
cytokines associated with onset of inﬂammation in early RP [32].
As such, the quantitative measure of macrophages is a reliable
indicator of the inﬂammation in early RP. The hypothesis that
lac/pyr changes may be a reﬂection of increased macrophage activ-
ity associated with RP is further supported by the strong correla-
tion coefﬁcient between macrophage count and lac/pyr for the
right lung (r = 0.86, p < 0.01) and the left lung (r = 0.85, p < 0.01)
(Fig. 4(e and f)). This hypothesis also seems to be supported by pre-
vious evidence associating increase in lac/pyr with inﬂammation in
other disease (arthritis) models [33]. The strong correlation be-
tween lac/pyr and macrophage count suggests that the enhanced
lac/pyr seen in the irradiated cohort is likely due to up regulation
of macrophage activity and the associated inﬂammation in RP.
Due to the small sample size for each cohort (n = 3), the t-tests pre-
sented above were performed under the assumption of unequal
variance. Nonetheless, with a sample size of n = 3 for each cohort,
the statistical power of this work is quite limited. Increasing the
sample size should result in more statistical power and better
quantiﬁcation of lac/pyr and macrophage count to further support
this hypothesis.
This proof-of-concept work demonstrates that early metabolic
changes (over days) can be mapped using hyperpolarized
13C-pyruvate MRSI in a rat model of RP involving conformal
radiotherapy. Increases in lac/pyr are highly correlated with
macrophage count in both the irradiated and unirradiated lungs
suggesting that part of the enhanced lac/pyr may be caused by
an increase in the number and activity of inﬁltrating macrophages
in response to inﬂammation. Future studies with larger sample size
could focus on the use of hyperpolarized 13C-pyruvate MRSI to
measure the regional effects on Radiation Pneumonitis arising
from varying conformal radiotherapy (dose, dose rate, fraction-
ation scheme, etc.) and intervention during the course of the injury
for the mitigation of RP.Conﬂict of interest
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